Verender Badial
Profile Verified by The Marque
Last Updated: 22 Sep 2026
CEO
London, GB
Profile Verified by The Marque
Last Updated: 22 Sep 2026
THE MARQUE
In Their Own Right
Biography
Verender S. Badial is a strategic investor, SEC-regulated CFO, and former investment banker with over 20 years’ leadership in global capital markets, M&A, SPACs, and strategic growth. He is recognised for delivering one of the few successful UK-founded de-SPAC transactions, managed entirely from the UK, and for raising and deploying capital from private equity, institutional investors, and family offices. With a track record spanning biotech, technology, and large-scale real estate, he has consistently scaled high-growth ventures and delivered long-term shareholder value.
Verender serves as a Board Member and Chair of the Audit Committee at JATT II and JATT III Acquisition Corps (NASDAQ-listed SPACs). Previously, he was co-Founder, Sponsor, and CFO of JATT Acquisition Corp, a NYSE-listed SPAC that raised $138M, and later CFO of Zura Bio Limited, a clinical-stage biotech firm listed on Nasdaq via a successful reverse merger. He was a key architect of the deal, leading fundraising, structuring, and investor engagement, and post-merger raised over $273M to drive growth. Verender also acts as CEO of ME Asset Management (ME|AM), an investment platform established in 2025 focused on building a diversified real estate portfolio with ESG integration and long-term value creation. ME|AM is backed by Cryfield Investments, the private investment and advisory platform Verender founded in 2015, whose capital-plus-strategy model has supported over £150M of ventures, including 500,000 sq ft of UK real estate developments.
Previously, Verender held Managing Director roles at ABN AMRO, Rothschild, and Société Générale, advising on landmark ECM/M&A transactions. His expertise spans IPOs, SPACs, cross-border financings, and complex strategic deals. Beyond business, Verender champions education in underserved communities and serves as Fundraising Director for a women’s nursing college in North India. He holds a degree in Actuarial Science from the London School of Economics.
The Record
Background
-
2015 — Present
Founder and Managing Director
Cryfield Investments Ltd
Cryfield Investments is a private investment and advisory firm founded by Verender Badial. The firm focuses on providing corporate finance advisory services and supporting capital fundraising activities, particularly for early-stage and growth-oriented businesses.
-
2025 — Present
CEO
ME Asset Management Ltd
ME Asset Management (ME|AM) is a UK property investment firm focused on acquiring and improving income-producing real estate. Through disciplined capital deployment and targeted upgrades, ME|AM repositions underperforming assets to unlock value and deliver attractive, risk-adjusted returns, strengthening income, resilience and long-term performance.
-
2023 — 2025
Chief Financial Officer
Zura Bio
Zura Bio is a Nasdaq-listed biotech company focused on developing therapies for immune and inflammatory disorders. It was formed through a merger with JATT Acquisition Corp in 2023. Zura Bio was targeted by JATT due to its strategy of advancing therapies that were previously developed and clinically validated by larger pharmaceutical companies but not fully pursued, saving time and money.
-
2010 — 2015
Managing Director (ECM)
Société Générale
Established in 1864, Société Générale is a major French multinational bank offering a full range of retail, corporate, and investment banking services across more than 60 countries, with over 119,000 employees. Its Equity Capital Markets (ECM) division offers equity fundraising services including IPOs, follow-on offerings, equity-linked instruments, and strategic equity advice.
-
2015 — 2018
Chief Financial Officer
Mackenzie Homes Ltd
Mackenzie Homes is a privately owned residential property developer focused on creating well-designed homes, particularly in the Western Corridor of Greater London. Specialising in mid-sized developments of 50 to 150 units near key transport links like Crossrail, the company uses local expertise to address the region's housing needs.
-
2021 — 2023
Chief Financial Officer
JATT Acquisition Corp
JATT Acquisition Corp was a special purpose acquisition company (SPAC) set up with the goal of merging with a life sciences or biotech business. In June 2022, JATT entered into a business combination agreement with Zura Bio, a clinical-stage biotech company. After the merger was approved in March 2023, JATT was renamed Zura Bio Limited and its shares began trading as ZURA on Nasdaq.
-
1996 — 2007
Director
ABN AMRO-Rothschild
ABN AMRO-Rothschild was a joint venture between NM Rothschild & Sons, a leading independent financial advisory group, and ABN AMRO, the Dutch banking group. The joint venture focused on equity capital markets (ECM) and aimed to combine Rothschild’s strength in advisory and client relationships with ABN AMRO’s distribution and underwriting capabilities. It was discontinued at the end of 2007.
-
2007 — 2008
Executive Director | Financial Sponsors' Team
Royal Bank of Scotland (RBS)
During the acquisition of ABN AMRO-Rothschild's equity capital markets business by Royal Bank of Scotland, Verender worked within RBS's Financial Sponsors’ team as an Executive Director focused on Structured Equity Financial Solutions.
-
2008 — 2010
Head of Corporate Advisory Services
Friend Partnership LLP
Friend Partnership LLP is a UK-based firm of chartered accountants and business advisors, with offices in Birmingham and London, offering accounting, audit, tax, corporate finance, and M&A services to businesses, both nationally and internationally.
-
1994 — 1996
M&A Associate
Wasserstein Perella & Co.
Wasserstein Perella & Co. was a prominent New York-based boutique investment bank founded in 1988 by Bruce Wasserstein and Joseph Perella, known for its expertise in M&A. The firm advised on some of the era’s most high-profile deals before being acquired by Dresdner Bank in 2000.
In The News
Newsfeed
-
26 August 2026 · Globe Newswire
JATT III Acquisition Corp Announces Closing of $69,000,000 Initial Public Offering
Read more -
29 June 2026 · PR Newswire
Talawar Therapeutics and JATT II Acquisition Corp. Announce Business Combination Agreement
Read more -
21 April 2026 · BriefGlance.com
JATT II Acquisition Corp Raises $60M for AI-Driven Biotech Hunt
Read more -
18 March 2026 · Property Magazine Int'l
ME Asset Management launches UK platform for complex assets
Read more -
18 March 2026 · Property Week
ME Asset Management launches platform targeting assets affected by building safety challenges
Read more -
3 February 2026 · Property Week
ME Asset Management snaps up Swansea Premier Inn
Read more -
1 July 2025 · Businesswire
Zura Bio Announces Chief Financial Officer Transition
Read more -
21 November 2023 · The Banker
Cracking the biotech market through smart investment
Read more -
16 March 2023 · Businesswire
JATT Acquisition Corp Shareholders Approve Proposed Business Combination with Zura Bio Limited
Read more
Formative Years
Education
-
Warwick Business School | University of Warwick
Financial Options Research Centre
1994 — 1996
-
London School of Economics
Actuarial Science, BSc
1990 — 1994
Areas Of Focus